Miguel N. Rivera

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• MYOD1 mutation drives cancer stem cell pathways and therapy-resistance in spindle cell/sclerosing rhabdomyosarcoma

  Nature Communications · 2026-06-03

• Impact Study of EV Grid Integration on a Nanogrid Scale Network

  2026-03-25

• p300/CBP is an essential driver of pathogenic enhancer activity and gene expression in Ewing sarcoma

  EMBO Reports · 2025-09-01 · 7 citations

• Abstract 5739: Small molecule modulation of autoinhibition to inhibit DNA binding of ERG and FLI1 - therapeutic for Ewing sarcoma, prostate cancer, and ALL

  Cancer Research · 2025-04-21

• 1543 Robust Off-Target EBV Detection in DNA- and RNA-based Next-generation Sequencing Analysis of Tumors

  Laboratory Investigation · 2025-03-01

• Abstract PR012: MYOD1L122R induces chemoresistance and elevates cancer stem cell programs through WNT11-ROR2-VANGL2 signaling in aggressive rhabdomyosarcoma

  Cancer Research · 2024-09-05

• EWS-WT1 fusion isoforms establish oncogenic programs and therapeutic vulnerabilities in desmoplastic small round cell tumors

  Nature Communications · 2024-08-28 · 12 citations

• Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma

  JCI Insight · 2024-07-21 · 3 citations